AR058862A1 - Polimeros que curan a temperatura ambiente - Google Patents

Polimeros que curan a temperatura ambiente

Info

Publication number
AR058862A1
AR058862A1 ARP060105719A ARP060105719A AR058862A1 AR 058862 A1 AR058862 A1 AR 058862A1 AR P060105719 A ARP060105719 A AR P060105719A AR P060105719 A ARP060105719 A AR P060105719A AR 058862 A1 AR058862 A1 AR 058862A1
Authority
AR
Argentina
Prior art keywords
polymers
polymer
methacrylate unit
room temperature
unit
Prior art date
Application number
ARP060105719A
Other languages
English (en)
Inventor
Hauenstein
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR058862A1 publication Critical patent/AR058862A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/442—Block-or graft-polymers containing polysiloxane sequences containing vinyl polymer sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/10—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/10—Block or graft copolymers containing polysiloxane sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/045—Polysiloxanes containing less than 25 silicon atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/14—Polysiloxanes containing silicon bound to oxygen-containing groups
    • C08G77/16—Polysiloxanes containing silicon bound to oxygen-containing groups to hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/14—Polysiloxanes containing silicon bound to oxygen-containing groups
    • C08G77/18—Polysiloxanes containing silicon bound to oxygen-containing groups to alkoxy or aryloxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Silicon Polymers (AREA)

Abstract

Métodos para hacer polímeros que curan a temperatura ambiente. Los reactivos incluyen polímeros terminados en siloxano y silanoles. Los reactivos se mezclan, y se deja suceder la polimerizacion al aire a temperatura ambiente. Los polímeros aceptan los uno o más compuestos terapéuticos. Por lo tanto, se peden recubrir dispositivos médicos desde los cuales es deseable una liberacion controlada de la droga (para administracion ya sea local o sistémica) con polímeros de la invencion que contienen el compuesto terapéutico. En una forma de realizacion preferida, se hace reaccionar con polidimetilsiloxano un polímero de poli(MPCw: LAMx: HPMAy: TSMAz) donde w, x, y , y z representan las proporciones molares de los manomeros que se utilizan en la materia prima para preparar el polímero; donde MPC representa la unidad2-metacriloiloxietilfosforilcolina, LMA representa la unidad metacrilato de laurilo, HPMA representa la unidad metacrilato de 2-hidroxipropilo, y TSMA representa la unidad metacrilato de 3-trimetoxisililproilo. En otra forma de realizacion preferida, se incorpora al polímero un compuesto terapéutico, como por ejemplo dexametasona.
ARP060105719A 2005-12-21 2006-12-21 Polimeros que curan a temperatura ambiente AR058862A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/314,372 US7906134B2 (en) 2005-12-21 2005-12-21 Room temperature-curable polymers

Publications (1)

Publication Number Publication Date
AR058862A1 true AR058862A1 (es) 2008-02-27

Family

ID=38173828

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060105719A AR058862A1 (es) 2005-12-21 2006-12-21 Polimeros que curan a temperatura ambiente
ARP170100608A AR107856A2 (es) 2005-12-21 2017-03-10 Método para preparar una composición; composición; dispositivo médico y stent

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP170100608A AR107856A2 (es) 2005-12-21 2017-03-10 Método para preparar una composición; composición; dispositivo médico y stent

Country Status (6)

Country Link
US (2) US7906134B2 (es)
EP (2) EP2537879B1 (es)
JP (1) JP5264501B2 (es)
AR (2) AR058862A1 (es)
TW (1) TWI402313B (es)
WO (1) WO2007076288A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198867A1 (en) * 1997-09-25 2006-09-07 Abbott Laboratories, Inc. Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
US8257726B2 (en) 1997-09-26 2012-09-04 Abbott Laboratories Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
US8057816B2 (en) * 1997-09-26 2011-11-15 Abbott Laboratories Compositions and methods of administering paclitaxel with other drugs using medical devices
EP2327429B1 (en) * 2005-03-23 2014-09-17 Abbott Laboratories Delivery of highly lipophilic agents via medical devices
PT1988910T (pt) 2006-02-28 2018-02-07 Kodiak Sciences Inc Acriloiloxietilfosforilcolina contendo conjugados de polímeros e sua preparação
US7673379B1 (en) 2007-05-11 2010-03-09 Abbott Cardiovascular Systems Inc. Method of producing a stent-balloon assembly
CN101977968B (zh) 2008-03-31 2013-03-13 株式会社资生堂 聚硅氧烷、丙烯酸系化合物及乙烯系化合物
US8187623B2 (en) * 2008-06-25 2012-05-29 Boston Scientific Scimed, Inc. Medical copolymers
US8802738B2 (en) * 2008-12-12 2014-08-12 University Of Massachusetts Polyesters with grafted zwitterions
JP2012530052A (ja) * 2009-06-15 2012-11-29 ディーエスエム アイピー アセッツ ビー．ブイ． ホスロリルコリンをベースにする医療用両親媒性シリコーン
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
US20150087687A1 (en) 2012-03-23 2015-03-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
EP3456643A1 (en) * 2012-04-13 2019-03-20 Dr. Py Institute, LLC Modular filling apparatus and method
SI3041513T1 (sl) 2013-09-08 2020-11-30 Kodiak Sciences Inc. Zwitterionski polimerni konjugati faktorja VIII
US10087526B2 (en) * 2013-12-20 2018-10-02 Microvention, Inc. Stents, packaging, and substances used with stents
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
EP3207128B1 (en) 2014-10-17 2022-07-27 Kodiak Sciences Inc. Butyrylcholinesterase zwitterionic polymer conjugates
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
AU2016381964B2 (en) 2015-12-30 2024-02-15 Kodiak Sciences Inc. Antibodies and conjugates thereof
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
EP3275909A1 (en) * 2016-07-27 2018-01-31 Clariant Plastics & Coatings Ltd Novel polyacrylate-polysilane block copolymers
BE1025004B1 (nl) 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
EP4041312A4 (en) 2019-10-10 2023-12-20 Kodiak Sciences Inc. METHOD FOR TREATING AN EYE DISORDER
CN111087686B (zh) * 2019-12-17 2021-09-17 金发科技股份有限公司 一种聚丙烯组合物及其制备方法和应用
CN111286033B (zh) * 2020-02-11 2022-02-18 合肥盖特环保技术有限责任公司 一种接枝聚硅烷类闪烁体及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870766A (en) * 1971-06-18 1975-03-11 Stauffer Chemical Co Method of curing organic polymers and copolymers
WO1986007541A1 (en) * 1985-06-19 1986-12-31 Yasushi Zyo Composition which can impart antithrombotic ability and medical apparatus to be in contact with blood
JPS6296562A (ja) * 1985-10-24 1987-05-06 Shin Etsu Chem Co Ltd シリコ−ン組成物
US5126400A (en) * 1990-07-30 1992-06-30 Dow Corning Corporation Reinforced polyorganosiloxane elastomers
US5705583A (en) * 1991-07-05 1998-01-06 Biocompatibles Limited Polymeric surface coatings
CA2277953C (en) * 1991-07-05 2001-01-16 Biocompatibles Limited Polymeric surface coatings
US6284854B1 (en) * 1991-07-05 2001-09-04 Biccompatibles Limited Polymeric surface coatings
US6090901A (en) * 1991-07-05 2000-07-18 Biocompatibles Limited Polymeric surface coatings
AU682667B2 (en) 1992-12-23 1997-10-16 Tremco, Inc. Alkoxysilane functionalized acrylic polymer composition
US6890546B2 (en) 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
US6015815A (en) * 1997-09-26 2000-01-18 Abbott Laboratories Tetrazole-containing rapamycin analogs with shortened half-lives
US5969075A (en) 1998-07-13 1999-10-19 Shin-Etsu Silicones Of America Process for the production of room temperature curable organopolysiloxane compositions
US6534600B2 (en) * 2001-03-26 2003-03-18 Michigan Molecular Institute Hyperbranched polyureas, polyurethanes, polyamidoamines, polyamides and polyesters
US6918869B2 (en) * 2002-12-02 2005-07-19 Scimed Life Systems System for administering a combination of therapies to a body lumen
TW200538433A (en) * 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
US20050208093A1 (en) 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions

Also Published As

Publication number Publication date
US20070141104A1 (en) 2007-06-21
WO2007076288A3 (en) 2007-12-06
EP1968486A2 (en) 2008-09-17
JP2009521489A (ja) 2009-06-04
US8475822B2 (en) 2013-07-02
EP2537879B1 (en) 2015-01-21
EP2537879A1 (en) 2012-12-26
WO2007076288A2 (en) 2007-07-05
EP1968486B1 (en) 2014-11-19
AR107856A2 (es) 2018-06-13
EP1968486A4 (en) 2010-03-03
TW200736340A (en) 2007-10-01
US20110123702A1 (en) 2011-05-26
TWI402313B (zh) 2013-07-21
JP5264501B2 (ja) 2013-08-14
US7906134B2 (en) 2011-03-15

Similar Documents

Publication Publication Date Title
AR058862A1 (es) Polimeros que curan a temperatura ambiente
CY1124517T1 (el) Επικαλυψεις απελευθερωσης φαρμακευτικης ουσιας για ιατρικες διαταξεις
ATE550050T1 (de) Medizinische geräte mit verbessertem wirkstoffreisetzungsprofil
UY28824A1 (es) Nuevos compuestos azufrados: uso como agentes de transferencia para la polimerización radicalaria controlada del ácido acrílico, polímeros obtenidos y sus aplicaciones
HK1135431A1 (en) Therapeutic applications of activation of human antigen-presenting cells through dectin-1
WO2009102465A3 (en) Continuous cell programming devices
WO2009012275A9 (en) Pyridone gpr119 g protein-coupled receptor agonists
RS53890B1 (en) STABILIZED POLYMER DELIVERY SYSTEM
ATE465205T1 (de) Polyglutamat-aminosäure-konjugate und verfahren
BR112015022625A8 (pt) microarranjo para entrega de agente terapêutico e métodos de utilização
DE602007000455D1 (de) Phosphorgefüllte, härtbare Silikonharz-Zusammensetzung und gehärtetes Produkt daraus
BRPI0919627A8 (pt) materiais de silicone curados com feixe de elétrons
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
ECSP109873A (es) Mezclas secas de material para construcción modificadas con polímero
DE602006010646D1 (de) Stent mit dünnem medikamentenabgebendem Film
CR20110515A (es) Compuesto biocompatible y su uso
WO2007092894A3 (en) Drug delivery system and method of manufacturing thereof
WO2010057984A3 (en) Photocurable polymeric dielectrics and methods of preparation and use thereof
BRPI0808560A2 (pt) composição de resina de polímero sililado curável por umidade
PH12017501527A1 (en) Oral hemostatic and wound-protective film
AR060693A1 (es) Metodos para hacer resinas poliester en reactores de policondensacion en estado fundido de pelicula descendente
ATE533624T1 (de) Lithografiedruckplattenvorläufer und plattenherstellungsverfahren dafür
BRPI0922246A2 (pt) copolímero contendo blocos de construção ácida e vários tipos de blocos de construção de poliéter.
BR112015027024A2 (pt) formulações de gel para liberação prolongada de compostos voláteis
BR112013030283A2 (pt) artigos compreendendo agente de revestimento à base de poliuretano reforçado

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee